back to Directory

BenchSci

BenchSci logo

Founded
2015
Patents
2
Publications
8

Technologies

AI Companies (Drug Discovery)

For biomedical researchers who are starting experiments, BenchSci is a reagent intelligence platform that transforms published data into experiment-specific recommendations to reduce time, money and uncertainty in planning materials and methods.

Unlike PubMed, Google Scholar, reagent directories and vendors, BenchSci uses machine learning to decode open- and closed-access data and present published figures with actionable insights.

reagent selection protein target AI-assisted selection antibody selection


Posts Mentioning This Company

Technology Meets Biology in Canada

  
Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) and quantum computing in life sciences.

Toronto’s Blossoming AI-driven Drug Discovery Scene

  
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep into the history of early programs and funding provided by Canadian Institute for Advanced Research (CIFAR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) to such AI …

Major VC Rounds For AI-driven Biotechs in 2020

  
The ongoing COVID19 crisis forced biotech-oriented venture capitalists (VC) to somewhat slow down the pace of their usual deal-flow -- according to data by PitchBook biopharma venture deals in 2020 are down roughly 16% compared to last year.  However, there is still a lot going on in drug discovery and …